openPR Logo
Press release

Inhaler Market Industry Size, Growth and Forecast to 2023

12-27-2019 11:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Inhaler Market Industry Size, Growth and Forecast to 2023

Inhaler Market Industry Size, Growth and Forecast to 2023

Global inhaler market is anticipated to grow at a CAGR of 2.7% during the forecast period. Rising level of air pollution is one of the major factors responsible for the increasing prevalence of lungs and cardiovascular diseases, which includes asthma and COPD. Urbanization is another prime contributor to asthma as it significantly increases the outdoor air pollution. According to World Health Organization (WHO), around nine out of every 10 people breathe polluted air, owing to which, nearly seven million mortalities occurs every year across the globe. This reflects the demand for inhalers for the treatment of asthma and COPD.

Request a free sample of our report on Inhaler Market: https://www.omrglobal.com/request-sample/inhaler-market

Moreover, increasing population base of smokers substantially increases the COPD patients, which in turn, spur the demand for inhalers in the global market. According to Institute of Health Metrics and Evaluation (IHME), in 2016, around 17 million fatalities occurred due to smoking in China. The rapidly growing attraction of youth towards smoking across the globe, which as a result motivating the market for inhalers in order to provide breathing solutions to the hugely affected population.

A full report of Global Inhaler Market is available at: https://www.omrglobal.com/industry-reports/inhaler-market

Significant prevalence of COPD has been recorded across the globe that is augmenting the demand for inhalers for its treatment. According to WHO, there were 251 million COPD cases were reported across the globe in 2016. Moreover, around 3.17 million mortalities were caused due to COPD in 2015, which is 5% of all the mortalities across the globe in 2016. The major cause of COPD is tobacco smoke and other factors such as occupational dusts and fumes as well as exposure to indoor or outdoor air pollution.

Some COPD cases occurs due to long-term asthma. It is expected to increase in future due to significant aging population and smoking prevalence across several countries. Over 90% of the mortalities occur in emerging economies. Moreover, according to WHO, 56.9 million mortalities were reported globally in 2016, of which more than half, that is 54% were occurred due to the top ten causes, including COPD, lower respiratory infections, and others.

Moreover, the increasing focus on the development of miniature and compact inhalers due to increasing penetration towards handy medical devices is providing a growth opportunity to the inhaler market. Healthcare providers have further started the development of smart inhalers, which supports Bluetooth technology, and works according to the health status of the patient. This, in turn, is anticipated to propel the global inhaler market in the near future. Some of the novel technologies introduced in the inhaler market is smart inhalers.

Current Market Trends Covered in the Global Inhaler Market Report

Based on the devices, the dry powder inhaler is estimated to hold a dominating market share during the forecast period.
Based on the application, asthma held the largest market share in the global inhaler market in 2018.
North America is estimated to dominate the global inhaler industry during the forecast period.

Global Inhaler Market Segmentation

By Device

Metered Dose Inhaler
Dry Powder Inhaler
Nebulizer
Nasal Inhaler

By Type

Preventive Inhaler
Reliever Inhaler
Long-acting bronchodilators

By Applications

Asthma
COPD

By End-User

Homecare
Hospitals and Clinics

Global Inhaler Market – Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/inhaler-market

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inhaler Market Industry Size, Growth and Forecast to 2023 here

News-ID: 1886473 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Inhaler

12-09-2024 | Health & Medicine
Getnews
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and